Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal
Loading...
Date
2014
Journal Title
Journal ISSN
Volume Title
Publisher
Contraception
Abstract
Sayana® Press (SP), a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in Uniject™, has potential to be a valuable innovation in family planning (FP) because it may overcome logistic and safety challenges in delivering intramuscular DMPA (DMPA IM). However, SP's acceptability is unknown. We measured acceptability of SP among DMPA IM users.
Study design: This open-label observational study was conducted in clinics in three districts in Senegal and community-based distribution services in two districts in Uganda. Experienced DMPA IM users were offered SP by community health workers (CHWs) or clinic-based providers. SP decliners were asked to discuss their reasons. Those who received SP were interviewed pre- and post injection and 3 months later, when they were asked if they would select SP over DMPA IM if it were available.
Description
Keywords
Depot medroxyprogesterone acetate, Subcutaneous injection, Contraception, Community health worker
Citation
Burke, H. M., Mueller, M. P., Perry, B., Packer, C., Bufumbo, L., Mbengue, D., ... & Mbonye, A. K. (2014). Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal. Contraception, 89(5), 361-367. http://dx.doi.org/10.1016/j.contraception.2014.01.022